Arbutus Biopharma Corp - FORM 10-K - EX-10.66 - EX 10.66 BILL SYMONDS EMPLOY AMEMD - March 22, 2017

Attached files

file filename
EX-32.2 - EXHIBIT 32.2 CFO SOX - Arbutus Biopharma Corpexhibit322_soxcertcfo.htm
EX-32.1 - EXHIBIT 32.1 CEO SOX - Arbutus Biopharma Corpexhibit321_soxcertceo.htm
EX-31.2 - EXHIBIT 31.2 10-K CFO - Arbutus Biopharma Corpexhibit312_10-kcertcfo.htm
EX-31.1 - EXHIBIT 31.1 10K CEO - Arbutus Biopharma Corpexhibit311_10-kcertceo.htm
EX-23.1 - EXHIBIT 23.1 - Arbutus Biopharma Corpexhibit231_kpmgconsent.htm
EX-21.1 - EXHIBIT 21.1 - Arbutus Biopharma Corpexhibit211_listingofsubsid.htm
EX-10.67 - EX 10.67 ALEXION LICENSE AGREEMENT - Arbutus Biopharma Corpexhibit1067alexionagreemen.htm
EX-10.65 - EX 10.65 CYTOS TERMINATION - Arbutus Biopharma Corpexhibit1065_cytosterminati.htm
EX-10.64 - EX 10.64 DICERNA TERMINATION - Arbutus Biopharma Corpexhibit1064_dicernatermina.htm
EX-10.63 - EXHIBIT 10.63 NEUROVIVE TERMINATION - Arbutus Biopharma Corpexhibit1063_neurovivetermi.htm
EX-10.62 - EX 10.62 DOD TERMINATION - Arbutus Biopharma Corpexhibit1062_dodtermination.htm
10-K - 10-K - Arbutus Biopharma Corparbutus10k2016.htm





Exhibit 10.66



3805 Old Easton Road    │    Doylestown, PA    │    United States 18902    │    Tel: 267.893.6650 │    www.arbutusbio.com



November 17, 2016


Personal and Confidential


Bill Symonds
103 Hardenbrook Court Cary, NC
USA, 27519



Dear Bill:

Effective November 15, 2016, your employment with Arbutus Biopharma Corp. (formerly Tekmira Pharmaceuticals Corp.) has been transferred to Arbutus Biopharma, Inc. Except for being employed by Arbutus Biopharma, Inc., all other terms of your employment will remain the same, as set forth in your Agreement to Serve as Chief Development Officer entered into as of May 29, 2015.


Very truly yours,

ARBUTUS BIOPHARMA, INC.

markjmurraysig.jpg

Mark J Murray President & CEO

Stock widget

Investing forum

Arbutus Biopharma Corp Reports